Tuesday, October 03, 2017 11:58:41 AM
Coinsguy,
We thank you for your continued support. Don’t worry we aren’t stopping to smell the roses with this one milestone.
You know I can’t speak of upcoming events and timing of communications.
In regards to the accreditation of our pesticide equipment, no issues to speak of, as mentioned we are subject to government bureaucracy. They have their timelines and processes to follow. ORELAP has set a tentative date to come out to our location, once firmed up I will share next steps.
Regards,
Will
William Waldrop
Chief Executive Officer
EVIO, Inc. (OTCQB: EVIO)
From: Coinsguy
Sent: Tuesday, October 3, 2017 6:05 AM
To: William Waldrop
Subject: Congratulations!
Dear Will,
Congratulations! We are now officially EVIO, Inc with ticker symbol EVIO. It took a lot of hard work to get us to this point, and we all owe you a debt of gratitude for making this all happen. Now that the deed is done, we are hoping you will have a string of PRs or 8Ks to release that will propel the stock price upwards. Do you?
Although I had to sell two-thirds of my holdings before the reverse split, I have reacquired those shares and now own 5,000 shares (500,000 before the reverse split) and did so at a lower price than what I had sold them for!
I do have one concern though that I hope you will be able to address. Why is it taking so long for the testing machine to be certified? Have there been any problems with doing so? Most members of my investment group (now with 1000 members) believe that the share price will continue to suffer until that certification is complete, as the external testing takes such a huge chunk out of our profits. What is the latest on this equipment?
Sincerely,
Coinsguy
Note: If there is a problem with anything I post, please be kind enough to drop me a private message and let me know what it is so that I can correct anything that violates this board's rules.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM